Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct
antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold …

Immune checkpoint inhibitors are a class of antineoplastic therapies that unleash immune
cells to kill malignant cells. There are currently 7 medications that have been approved by …

There are not many publications that provide a holistic view of the management of primary
and secondary ITP as a whole, reflecting the similarities and differences between the two …

Introduction The direct antiglobulin test (DAT) or Coombs test is the cornerstone of the
diagnosis of autoimmune hemolytic anemia (AIHA). It can be performed by several methods …

Paraneoplastic syndromes (PNS) are a group of disorders that can affect the oncologic
patient, and which are not directly attributable to tumour invasion, tumour compression or …

Immune thrombocytopenia (ITP) is a rare autoimmune condition, due to peripheral platelet
destruction through antibody-dependent cellular phagocytosis, complement-dependent …

Simple Summary This review analyzes the occurrence, clinical characteristics, and
prognostic impact and treatment of autoimmune hemolytic anemia (AIHA) in chronic …

Low-risk myelodysplastic syndromes (LR-MDS) are a very heterogeneous disease, with
extremely variable clinical features and outcome. Therapeutic strategies are still limited and …

GATA2 deficiency is a disease with a broad spectrum of clinical presentation, ranging from
lymphedema, deafness, pulmonary dysfunction to miscarriage and urogenital anomalies …

Introduction Medicine stands at the threshold of a new era heralded by the vast potential of
cell engineering. Like advances made possible by genetic engineering, current prospects …